Biosimilars beware – Trademarks are important too!
The Federal Court of Appeal confirmed that the name BYOOVIZ (for an anti-vascular endothelial growth factor [anti-VEGF] biosimilar) infringed and passed off...Read More
Assessing TM Confusion: Patients Matter
Novartis v. Biogen involves claims of trademark infringement, passing off and depreciation of goodwill and raises several interesting issues. The Applicants, Novartis...Read More